Searched for
SHAMNAD BASHEER
Delhi High Court seeks reply of UIDAI, Centre on plea raising concern over Aadhaar data securityThe bench listed the matter for further hearing on November 19.- Young Hyderabad girl is here to make lawyers out of the marginalisedAnusha Reddy started training five blind students for the Common Law Admission Test (CLAT).
- IPR policy lacks specifics, won't be enough to foster innovation: Lobby groupsSome experts said the policy is an attempt to calm the nerves of India’s trade partners – especially the US – but has left stakeholders wan...
- Certain provisions in Trademarks Act unconstitutional: Madras High CourtMadras High Court declared asunconstitutional a sub-section of Trade Marks Act, 1999 whichqualifies a member of Indian Legal Service to the...
- Narendra Modi government-led IPR think tank mulls new utility model lawSeveral experts have argued for some form of IP protection for what is commonly known as ‘jugaad innovation’ that takes place across sector...
- Government may propose sub-groups on other contentious issues under ambit of IPR panelDuring PM Modi’s visit to the US, the two countries committed to set up an annual high-level IP working group as part of the trade policy f...
- High Court issues notice on PIL over disclosure policy of Patents ActThe government arms are misusing these grey areas to frustrate RTI seekers and conceal information, which they should be readily sharing un...
- PIL seeks clarity on whether pre-existing laws override RTIThe court admitted the matter on Wednesday and sent out notice to the government seeking its response.
- Linking patented drug price to per capita income may hit generic drug makers: ExpertsA government panel's proposal to link the price of patented drugs to per capita income is likely to shut out the option of compulsory licen...
- Natco Pharma begins sales of Bristol Myers' cancer drug DasatinibHyderabad-based generic drugmaker Natco Pharma has started selling copies of global pharma major Bristol Myers Squibb's cancer drug Dasatin...
- Govt plans to make public details of patented drugsA generic drugmaker can seek 'compulsory licensing', a provision that allows generic company to legally make and sell cheaper version of th...
- Non-compliance with disclosure norms on patents may bring trouble for pharma companiesSeveral global drugmakers, including Pfizer, Roche and Bayer, have not met full mandatory disclosures of their patented medicines in India,...
- Writ petition says IP tribunal incompetentA group of patent lawyers have filed a writ petition challenging the legality of the country's highest technical body for intellectual prop...
- Govt suspends senior official for ‘improper’ patent grant to BraunMove follows investigation by Controller General of Patents, HP Kurian, who found ‘irregularity’ related to patent granted to Braun for Saf...
- Court asks Matrix not to sell generic of Roche’s cancer drugThe Madras High Court (HC) has asked Hyderabad-based Matrix Laboratories not to make or sell the generic version of Swiss major Roche’s can...
- Lack of clarity in drugs Act may hit generic companiesAmbiguity in terms such as 'adulterated' & 'spurious' may complicate patent challenge & regulation of firms
- Cipla gets relief as SC rejects Roche pleaThe Supreme Court on Friday rejected Swiss drugmaker Roche’s petition to stop Indian firm Cipla from selling the generic version of its can...
- Novartis to challenge IPAB’s patent decision on GlivecThe Indian subsidiary of Swiss drugmaker Novartis will challenge a decision by the Intellectual Property Appellate Board (IPAB) that said i...
- Novartis not ready to give up on GlivecThe Indian subsidiary of Swiss drugmaker Novartis will challenge a decision by the Intellectual Property Appellate Board (IPAB) that said i...
- Remember the Mashelkar panel report?Dr Mashelkar, who has not responded to repeated reminders from the government, says it is no more his responsibility to re-submit patent la...
Load More
